NVCHI
EGRX

New Vernon Capital Holdings II’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

New Vernon Capital Holdings II’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,918
Closed -$202K – 49
2018
Q3 		$202K Hold
2,918
– – 0.21% 47
2018
Q2 		$221K Buy
+2,918
New +$221K 0.24% 40